Liquidia targets at least $1B net revenue in 2027 as YUTREPIA Q1 net product sales rise 44% sequentially
Liquidia Corporation Common Stock · PHARMACEUTICAL PREPARATIONS · Now $58.74
+16% in 7d after detection
Post-detection moves
1h
—
1d
+6.5%
3d
+12%
7d
+16%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS